Skip to content

SANUWAVE Health, Inc. SNWV Change In Fair Value Of Derivative Liabilities

Change In Fair Value Of Derivative Liabilities at other companies

KLR
Kalaris Therapeutics, Inc. Common StockKLRS
$0-100%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$1.65M0.0%
American Battery Technology Company logo
American Battery Technology CompanyABAT
$705.18K
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$480K+26.3%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$39K-32.8%
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
-$5.94M+56.8%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept snwv:ChangeInFairValueOfDerivativeLiabilities.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s change in fair value of derivative liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s change in fair value of derivative liabilities?
SANUWAVE Health, Inc. (SNWV) reported change in fair value of derivative liabilities of $0 in Q1 2026.
How has SANUWAVE Health, Inc.'s change in fair value of derivative liabilities changed year-over-year?
SANUWAVE Health, Inc.'s change in fair value of derivative liabilities decreased by 100.0% year-over-year, from $4.9M to $0.
What is the long-term trend for SANUWAVE Health, Inc.'s change in fair value of derivative liabilities?
Over 3 years (2021 to 2025), SANUWAVE Health, Inc.'s change in fair value of derivative liabilities has grown at a 45.7% compound annual growth rate (CAGR), from $2.62M to -$8.11M.
What does change in fair value of derivative liabilities mean?
The periodic gain or loss recognized in the income statement resulting from the revaluation of derivative financial instruments, such as warrants or embedded conversion features. Fluctuations in this metric are often driven by changes in the company's underlying stock price or volatility assumptions. It represents non-cash accounting adjustments that can significantly impact net income despite having no immediate effect on operating cash flow.